Tag: ITI-1001

Immunomic Therapeutics begins ITI-1001 Phase 1 trial in glioblastoma

businessnewstoday- August 24, 2023 0

Immunomic Therapeutics, Inc., a clinical-stage biotech company specializing in nucleic acid immunotherapy platforms, has dosed the first patient in a Phase 1 clinical trial of ... Read More